Praxis Precision Medicines effects 1-for-15 reverse stock split effective Nov 28, 2023

Praxis Precision Medicines, Inc.

Every 15 shares of common stock reclassified into 1 share; no change in authorized shares or par value.
No fractional shares issued; cash payment based on closing price on Nov 28, 2023.
Trading on Nasdaq begins split-adjusted on Nov 29, 2023 under same symbol PRAX; new CUSIP 74006W207.
Updated selected financial data in Exhibit 99.1 retroactively adjusts per-share amounts for the split.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Praxis Precision Medicines, Inc.: Filing of Certificate of Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-15 reverse stock split (effective 2023-11-28).

Change: charter amendment
Effective: 2023-11-28

Exact text from the filing

On November 28, 2023, Praxis Precision Medicines, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to effect a 1-for-15 reverse stock split of its common stock (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001689548-23-000162

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.